[HTML][HTML] Pre-exposure to mRNA-LNP inhibits adaptive immune responses and alters innate immune fitness in an inheritable fashion

Z Qin, A Bouteau, C Herbst, BZ Igyártó - PLoS Pathogens, 2022 - journals.plos.org
Hundreds of millions of SARS-CoV-2 mRNA-LNP vaccine doses have already been
administered to humans. However, we lack a comprehensive understanding of the immune …

[HTML][HTML] A single immunization with nucleoside-modified mRNA vaccines elicits strong cellular and humoral immune responses against SARS-CoV-2 in mice

D Laczkó, MJ Hogan, SA Toulmin, P Hicks, K Lederer… - Immunity, 2020 - cell.com
SARS-CoV-2 infection has emerged as a serious global pandemic. Because of the high
transmissibility of the virus and the high rate of morbidity and mortality associated with …

[HTML][HTML] Variant-specific vaccination induces systems immune responses and potent in vivo protection against SARS-CoV-2

L Peng, PA Renauer, A Ökten, Z Fang, JJ Park… - Cell Reports …, 2022 - cell.com
Lipid nanoparticle (LNP)-mRNA vaccines offer protection against COVID-19; however,
multiple variant lineages caused widespread breakthrough infections. Here, we generate …

[HTML][HTML] Multiplexed LNP-mRNA vaccination against pathogenic coronavirus species

L Peng, Z Fang, PA Renauer, A McNamara, JJ Park… - Cell Reports, 2022 - cell.com
Although COVID-19 vaccines have been developed, multiple pathogenic coronavirus
species exist, urging on development of multispecies coronavirus vaccines. Here we …

Innate immune mechanisms of mRNA vaccines

R Verbeke, MJ Hogan, K Loré, N Pardi - Immunity, 2022 - cell.com
The lipid nanoparticle (LNP)-encapsulated, nucleoside-modified mRNA platform has been
used to generate safe and effective vaccines in record time against COVID-19. Here, we …

[HTML][HTML] Langerhans cells and cDC1s play redundant roles in mRNA-LNP induced protective anti-influenza and anti-SARS-CoV-2 immune responses

S Ndeupen, A Bouteau, C Herbst, Z Qin… - PLoS …, 2022 - journals.plos.org
Nucleoside modified mRNA combined with Acuitas Therapeutics' lipid nanoparticles (LNPs)
has been shown to support robust humoral immune responses in many preclinical animal …

[HTML][HTML] Durable cross-protective neutralizing antibody responses elicited by lipid nanoparticle-formulated SARS-CoV-2 mRNA vaccines

KH Bae, B Shunmuganathan, L Zhang, A Lim, R Gupta… - npj Vaccines, 2024 - nature.com
The advent of SARS-CoV-2 variants with defined mutations that augment pathogenicity
and/or increase immune evasiveness continues to stimulate global efforts to improve …

[HTML][HTML] Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines

X Han, MG Alameh, K Butowska, JJ Knox… - Nature …, 2023 - nature.com
Lipid nanoparticle (LNP)-formulated messenger RNA (mRNA) vaccineare a promising
platform to prevent infectious diseases as demonstrated by the recent success of SARS-CoV …

[HTML][HTML] An mRNA vaccine encoding the SARS-CoV-2 receptor-binding domain protects mice from various Omicron variants

R Uraki, M Imai, M Ito, S Yamayoshi, M Kiso, N Jounai… - npj Vaccines, 2024 - nature.com
Here, we assessed the efficacy of a lipid nanoparticle-based mRNA vaccine candidate
encoding the receptor-binding domain (LNP-mRNA-RBD) in mice. Mice immunized with …

[HTML][HTML] Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2

Z Fang, L Peng, R Filler, K Suzuki, A McNamara… - Nature …, 2022 - nature.com
The Omicron variant of SARS-CoV-2 recently swept the globe and showed high level of
immune evasion. Here, we generate an Omicron-specific lipid nanoparticle (LNP) mRNA …